US Patent 8114630 Modified interferon beta polypeptides and their uses
Patent 8114630 was granted and assigned to Ambrx on February, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+83 characters)
Article
Patent abstract
Modified interferon beta polypeptides and uses thereof are provided.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08114630 Modified interferon beta polypeptides and their uses US Patent 8114630 Modified interferon beta polypeptides and their uses
Infobox
Patent Number
0811463000
Patent Number
811463000
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081146300
Date of Patent
February 14, 2012
0Patent Application Number
121128900
Date Filed
April 30, 2008
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081146300
Date of Patent
February 14, 2012
0Patent Application Number
121128900
Date Filed
April 30, 2008
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08114630 Modified interferon beta polypeptides and their uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08114630
Date of patent
February 14, 2012
Patent application number
12112890
Date Filed
April 30, 2008
Patent primary examiner
Find more entities like US Patent 8114630 Modified interferon beta polypeptides and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
